All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Policy makers encourage collaborative decision making in health care \[[@pone.0128228.ref001]--[@pone.0128228.ref003]\] aimed at reaching a mutual agreement between patient and clinician on which treatment to choose, taking into account the best available evidence, as well as patients' values and preferences \[[@pone.0128228.ref004]\].

Many decisions around vascular access for haemodialysis warrant a collaborative decision-making process. Firstly because numerous aspects of access creation and subsequent maintenance (e.g., selection of access type, infection prevention) may profoundly influence patients' lifestyle and psychosocial well-being \[[@pone.0128228.ref005]\], or could benefit from patients' adherence or self-management skills\[[@pone.0128228.ref006]\]. Furthermore, the underlying evidence base for several vascular access-related choices is weak or flawed. For example, when choosing how to preoperatively assess vessels for fistula suitability, it is uncertain whether the potential benefits of more invasive tests outweigh potential harm compared to a clinical examination \[[@pone.0128228.ref007]\]; and a systematic review found a high risk of selection bias in studies exploring the association between access type and outcomes \[[@pone.0128228.ref008]\].

Despite the apparent need for making decisions on vascular access collaboratively, previous research suggested that patients' experiences in this regard were suboptimal \[[@pone.0128228.ref005],[@pone.0128228.ref009]\]. This potentially leads to patients feeling emotionally unprepared for vascular access \[[@pone.0128228.ref005]\], perceiving a lack of choice regarding renal replacement therapy \[[@pone.0128228.ref009]\], or being reluctant to consider a fistula after starting haemodialysis on a catheter \[[@pone.0128228.ref010],[@pone.0128228.ref011]\]. The suboptimal decision-making process may partly stem from the lack of support to make collaborative and informed choices around vascular access. Clinical practice guidelines have been suggested as a starting point to provide such support \[[@pone.0128228.ref012]--[@pone.0128228.ref014]\]. However, they often strongly focus on the clinicians' side of decision making by only synthesizing the best available evidence, while failing to incorporate the influence of patients' preference and their clinical and socio-personal context \[[@pone.0128228.ref015]\].

European Renal Best Practice (ERBP) produces guidance for health professionals who provide care to kidney patients in Europe and neighboring regions ([www.european-renal-best-practice.org](http://www.european-renal-best-practice.org)). Within the context of updating its 2007 vascular access guideline \[[@pone.0128228.ref016]\], ERBP surveyed an international panel of kidney patients and clinicians about their perspectives on what decisions related to vascular access care deserved priority for coverage by the updated guideline. Exploring and comparing both perspectives will provide pointers for developing guidance that contributes to optimizing collaborative vascular access decision making.

Methods {#sec006}
=======

The process of identifying and prioritizing all relevant treatment decisions along the vascular access care pathway (vascular access 'topics') comprised three phases ([Fig 1](#pone.0128228.g001){ref-type="fig"}). In phase 0, we created a preliminary list of topics based on a literature review, and input from a multidisciplinary expert group. This group consisted of two kidney patients, two nephrologists, a renal nurse, two surgeons, and a radiologist. In phase 1, an international panel of clinicians and kidney patients rated the priority of these topics, as well as suggesting additional topics to complement the preliminary list. The additional topics were prioritized in phase 2.

![Flow chart of process of identifying and prioritizing treatment decisions (i.e., topics) around permanent vascular access](pone.0128228.g001){#pone.0128228.g001}

Developing the questionnaire {#sec007}
----------------------------

We first explored which clinical topics related to permanent vascular access care were addressed in randomized studies, systematic reviews, meta-analyses by searching the Cochrane database, combining MeSH terms and keywords related to vascular access, kidney disease, and dialysis ([S1 File](#pone.0128228.s001){ref-type="supplementary-material"}). Based on title and abstract, two reviewers (SV and MH) extracted the primary topic addressed in each study. They also reviewed available English language guidelines \[[@pone.0128228.ref016]--[@pone.0128228.ref019]\] for additional topics. Based on the exploratory review, we drafted a topic list, which the expert group reviewed and complemented; this resulted in a preliminary list of 39 topics, which respondents prioritized in the phase 1 questionnaire; they could also suggest additional topics. This generated three new topics (prioritized in phase 2), resulting in a final list of 42 topics; ten referred to general aspects of access care, 25 specifically to fistulas/grafts, and seven to permanent catheters (see [S2 File](#pone.0128228.s002){ref-type="supplementary-material"}). While clinicians prioritized all, patients rated only the general topics, and those referring to the access type with which they had most experience.

All participants rated the priority of topics on an unbalanced 5-point Likert scale \[[@pone.0128228.ref020]\], with a rating of 1 indicating 'not important' and the other four indicating some degree of importance (ranging from 2 'a little important' to 5 'very important'). Patients could indicate that they were unable to rate a topic\'s priority, e.g., because they needed more information.

Two sets of cues \[[@pone.0128228.ref021]\] aimed to align the concept of priority among respondents. Clinicians' cues focused on prioritizing topics reflecting decisions with considerable impact on patient outcomes, for which there was insufficient or conflicting evidence on what to do, or that were prevalent in clinical practice \[[@pone.0128228.ref022]\]. Cues for patients tried to capture topics for which respondents strongly preferred some treatment options to others while assuming medical equipoise.

All questionnaires were electronic and developed in SurveyMonkey. Questionnaires for clinicians were in English, and pilot-tested by our expert group. Patients received questionnaires professionally translated from English into their native language, and reviewed for clarity by two native speakers (one kidney patient, one clinician).

The complete questionnaires are provided as ([S2 File](#pone.0128228.s002){ref-type="supplementary-material"}).

Recruitment of participants {#sec008}
---------------------------

### Kidney patients {#sec009}

We recruited patients from Austria, Dutch-speaking Belgium, Spain, the Netherlands, and the United Kingdom via national patient organizations, or--in the absence of such an organization in Belgium---via nephrologists in five dialysis centres. Patients were eligible to participate if they (1) had been on haemodialysis for at least 91 consecutive days, and (2) had an e-mail address, which they accessed regularly. Finally, 101 patients consented and received an invitation for phase 1. For phase 2, we invited all patients who completed phase 1.

### Clinicians {#sec010}

For phase 1 we approached various clinician groups involved in vascular access care via the European Renal Association--European Dialysis and Transplant Association, European Society of Vascular Surgery, Vascular Access Society (VAS), VAS of Britain and Ireland, and national professional networks for renal nurses in Dutch-speaking Belgium, Italy, Spain, and the Netherlands. Dissemination strategies varied between societies, including undirected e-mail blasts to all members, direct mailings, and a link in electronic newsletters or on societies' website. For phase 2, we invited 764 clinicians from phase 1 who indicated their interest in further participation.

Data collection and analysis {#sec011}
----------------------------

We collected data in SurveyMonkey ([www.surveymonkey.com](http://www.surveymonkey.com)) between February and October 2014. For both surveys, participants received up to two reminders after three and six weeks.

We summarized data using descriptive statistics as appropriate. In all analyses, we distinguished patients, nephrologists, nurses, and surgeons/radiologists as separate respondent groups.

We calculated standardized ratings (rating~std~) for each individual before calculating mean ratings within each respondent group to account for the phenomenon that different people tend to use different ranges of a rating scale \[[@pone.0128228.ref020]\]. Per topic, we subtracted a respondent\'s mean rating across all topics from the original rating, and divided the result by the respondent\'s standard deviation \[[@pone.0128228.ref023]\]. Using each respondent group's mean rating~std~, we then compared priorities between patients and each clinician group by performing two-sample t-tests per topic. To correct for multiple testing, we considered a p-value \< 0.01 to indicate a statistically significant difference in priority rating.

For ease of interpretation we back-transformed the rating~std~ to the original scale for reporting priority ratings in the text and main tables (referred to as adjusted ratings, rating~adj~), as follows. We calculated the overall mean and standard deviation, using the original ratings across all topics and respondents. Subsequently, we multiplied each respondent\'s standardized ratings by the overall standard deviation, and added the overall mean.

We performed all analyses using IBM SPSS Statistics for Windows version 20.0.0.1.

Ethical approval {#sec012}
----------------

The Research Ethics Committee of Ghent University Hospital (Ghent, Belgium) approved the study. The committees of the Academic Medical Center (Amsterdam, The Netherlands), Barts Health NHS Trust (London, UK), Consorci General University Hospital (Valencia, Spain), and Medical University of Vienna (Vienna, Austria) informed us that they did not deem formal approval necessary.

Results {#sec013}
=======

Participants {#sec014}
------------

[Table 1](#pone.0128228.t001){ref-type="table"} displays all participants\' characteristics.

10.1371/journal.pone.0128228.t001

###### Participants' characteristics.[^a)^](#t001fn001){ref-type="table-fn"}

![](pone.0128228.t001){#pone.0128228.t001g}

  Characteristics                             Number (%)[^b)^](#t001fn002){ref-type="table-fn"}
  ------------------------------------------- ---------------------------------------------------
  *Kidney patients (n = 85)*                  
  Country of residence                        
      Austria                                 13 (15)
      Belgium                                 20 (24)
      Spain                                   12 (14)
      The Netherlands                         25 (29)
      United Kingdom                          15 (18)
  Age (years)                                 
      \< 35                                   10 (12)
      35 to 50                                23 (27)
      51 to 65                                35 (41)
      \> 65                                   17 (20)
  Male                                        29 (34)
  Currently on haemodialysis                  74 (87)
  Total time on haemodialysis (years)         
      \< 1                                    9 (11)
      1 or 2                                  22 (26)
      3 to 5                                  17 (20)
      \> 5                                    37 (44)
  Pre-dominantly dialyzed via. ...            
      ... an arteriovenous fistula or graft   76 (89)
       ...a tunneled catheter                 9 (11)
  *Clinicians (n = 1021)*                     
  Country of practice                         
      Spain                                   116 (11)
      Germany                                 95 (9)
      Italy                                   88 (9)
      United Kingdom                          77 (8)
      Belgium                                 65 (6)
      Other                                   580 (57)
  Age (years)                                 
      \< 35                                   92 (9)
      35 to 50                                450 (44)
      51 to 65                                431 (42)
      \> 65                                   48 (5)
  Male                                        654 (64)
  Practising as a                             
      Nephrologist                            687 (67)
      Nurse                                   194 (19)
      Surgeon                                 126 (12)
      Radiologist                             14 (1)
  Clinical experience (years)                 
      \< 5                                    79 (8)
      5 to 10                                 153 (15)
      11 to 20                                311 (31)
      \> 20                                   478 (47)
  Time spent in direct patient care (%)       
      \< 25                                   46 (4)
      25 to 50                                130 (13)
      51 to 75                                334 (33)
      \> 75                                   511 (50)

^a)^ Participants in phase 1

^b)^ Percentages may not add up to 100% due to rounding off

Of the 101 consenting kidney patients who received an invitation for phase 1, 85 responded (response rate \[RR\], 84%). The majority were 51 to 65 years of age, and female, had been on haemodialysis for more than five years, and were receiving haemodialysis at the time of the study; 76 (89%) had most experience with dialysis via a fistula or graft. The characteristics of the 50 patients who completed the phase 2 survey (RR, 59%) were similar to those participating in phase 1.

In total, 1021 clinicians from 92 countries completed the questionnaire in phase 1; our method of distribution did not allow us to ascertain a response rate. The majority were aged 35 to 50 years, male, were practicing as a nephrologist, had over twenty years of clinical experience, and spent most of their time in direct patient care. Of the 764 clinicians invited for phase 2, 425 responded (RR, 56%), with similar characteristics to clinicians in phase 1.

Topic prioritization {#sec015}
--------------------

In total, we included 43 782 original ratings, with an overall mean of 4.20 (standard deviation \[SD\], 0.46). The mean rating~adj~ and priority ranking for all topics per respondent group ([S3 File](#pone.0128228.s003){ref-type="supplementary-material"}), as well as all individual survey responses ([S4 File](#pone.0128228.s004){ref-type="supplementary-material"}) are provided.

### Kidney patients {#sec016}

The overall mean for patients across all original ratings was 4.18 (SD, 0.48). On 30 occasions (\<1% of all ratings) sixteen different patients indicated to be unable to rate at least one topic's priority. [Table 2](#pone.0128228.t002){ref-type="table"} presents the ten topics to which patients assigned highest priority, with \'managing catheter thrombosis\' occupying the top position. Overall, \'managing needle phobia\' (mean rating~adj~, 3.69; SD, 0.57), \'catheter insertion methods\' (mean rating~adj~, 3.82; SD, 0.52), and \'managing pain during cannulation\' (mean rating~adj~, 3.90; SD, 0.65) received the lowest priority.

10.1371/journal.pone.0128228.t002

###### Comparing priority ratings between kidney patients and clinicians for the ten topics to which *patients* assigned highest priority.

Abbreviations: N, number of respondents who rated the importance of a topic; SD, standard deviation.

![](pone.0128228.t002){#pone.0128228.t002g}

                                                                                        KIDNEY PATIENTS   CLINICIANS                                                                                                       
  ------------------------------------------------------------------------------------- ----------------- ------------ ------------- ---- ------------- -------------- ---- ------------- ------------- ---- ------------- --------------
  Catheter thrombosis                                                                   1                 9            4.47 (0.33)   14   4.33 (0.33)   0.25           11   4.33 (0.33)   0.24          28   4.12 (0.37)   **0.011**
  Selection of vascular access type [^c)^](#t002fn003){ref-type="table-fn"}             2                 85           4.39 (0.29)   2    4.49 (0.31)   **\< 0.01**    9    4.34 (0.37)   0.22          1    4.57 (0.24)   **\< 0.001**
  Training clinicians to create/maintain access                                         3                 85           4.37 (0.41)   13   4.34 (0.34)   0.53           14   4.32 (0.34)   0.35          8    4.41 (0.36)   0.41
  Catheter infection                                                                    4                 9            4.36 (0.19)   1    4.53 (0.27)   0.03           1    4.49 (0.27)   0.08          18   4.30 (0.37)   0.40
  Fistula/graft infection                                                               6                 76           4.35 (0.36)   4    4.40 (0.33)   0.26           3    4.41 (0.29)   0.21          16   4.31 (0.32)   0.36
  Perioperative fistula/graft infection                                                 5                 76           4.34 (0.34)   22   4.27 (0.41)   0.08           4    4.40 (0.33)   0.21          23   4.20 (0.46)   **\< 0.01**
  Preoperative assessment of vessels                                                    7                 85           4.33 (0.40)   18   4.30 (0.38)   0.42           24   4.20 (0.41)   **0.012**     5    4.49 (0.34)   **\< 0.01**
  Fistula/graft-related heart disease                                                   8                 71           4.33 (0.40)   29   4.11 (0.41)   **\< 0.001**   30   4.15 (0.37)   **\< 0.01**   35   3.99 (0.40)   **\< 0.001**
  Selection of vascular access site                                                     9                 85           4.32 (0.36)   5    4.40 (0.35)   0.08           15   4.32 (0.36)   0.87          4    4.50 (0.27)   **\< 0.001**
  Strategies to organize vascular access care [^d)^](#t002fn004){ref-type="table-fn"}   10                85           4.31 (0.37)   21   4.28 (0.37)   0.45           16   4.31 (0.35)   0.87          6    4.42 (0.34)   0.04

^a)^ Ranking based on mean (standard deviation) standardized ratings

^b)^ Based on two sample t-test of mean standardized ratings between patients and clinician group. P-values of \<0.01 indicate a disagreement on priorities between patients and clinicians, with values between 0.010 and 0.014 being considered borderline significant.

^c)^ Topic includes subtopics such as choosing between fistula, graft and tunneled catheter; clinical and social (contra-)indications for specific access types; last resort access types

^d)^ Topic includes subtopics such as who should create fistulas; specialized vascular access centres; multidisciplinary vascular access teams; vascular access coordinators; formalized care pathways

### Clinicians {#sec017}

For nephrologists, nurses, and surgeons/radiologists, the overall mean original ratings were 4.18 (SD, 0.44), 4.42 (SD, 0.38), and 3.99 (SD, 0.53), respectively. The following four topics appeared in the top 10 priority ranking of all groups: 'selection of vascular access type'; 'preservation of veins'; 'management of fistula/graft stenosis'; and 'management of central vein obstruction'. Nephrologists and nurses assigned highest priority to 'preventing catheter infections' (mean (SD) rating~adj~ of 4.53 (0.27) and 4.49 (0.27), respectively). Surgeons/radiologists ranked this topic 18^th^ (mean rating~adj~, 4.30; SD, 0.37), and gave top priority to 'selection of vascular access type' (mean rating~adj~, 4.57; SD, 0.24). 'Management of perigraft seromas' was at the bottom of the overall ranking for all clinician groups, with a mean (SD) rating~adj~ of 3.54 (0.61), 3.53 (0.75) and 3.58 (0.55) for nephrologists, nurses, and surgeons/radiologists, respectively.

Differences in priority ratings between patients and clinicians {#sec018}
---------------------------------------------------------------

Patients' priorities differed significantly for thirteen topics when compared to nephrologists, thirteen when compared to surgeons/radiologists, and for seven topics when compared to nurses (supplement material). In general, patients assigned higher priority than clinicians to topics regarding managing adverse effects of arteriovenous access and patient involvement in care (compared to nephrologists), while giving lower priority to decisions around preparing for access creation, the surgical procedure, and preventing poor fistula maturation. For 23 of 42 topics, priority ratings did not differ significantly between patients and any clinician group; this included five of the ten top priority topics for patients ([Table 2](#pone.0128228.t002){ref-type="table"}).

### Differences in ratings between groups for patients' high priority topics {#sec019}

[Table 2](#pone.0128228.t002){ref-type="table"} shows that we found a statistically (borderline) significant difference for ten of 30 comparisons concerning patients' top priority topics; six stemmed from patients rating topics differently from surgeons/radiologists. Patients assigned higher priority than clinicians to 'managing fistula/graft-related heart disease' (compared to any clinician group); 'catheter thrombosis' and 'preventing perioperative fistula/graft infections' (compared to surgeons/radiologists); and 'preoperative assessment of vessels' (compared to nurses). Patients assigned lower priority to 'selection of vascular access type' (compared to nephrologists and surgeons/radiologists), and 'preoperative assessment of vessels' and 'selection of vascular access site' (compared to surgeons/radiologists).

### Differences in ratings between groups for clinicians' high priority topics {#sec020}

[Table 3](#pone.0128228.t003){ref-type="table"} displays comparisons for the eight topics that were absent in the patient top 10, but appeared in the top 10 priority ranking of one or more clinician group. Clinicians assigned a higher priority rating than patients to 'preservation of veins' and 'management of fistula/graft stenosis' (all groups); 'timing of vascular access creation' and 'surgical techniques for fistula/graft creation' (nephrologists and surgeons/radiologists).

10.1371/journal.pone.0128228.t003

###### Comparing priority ratings between kidney patients and clinicians for topics to which *clinicians* assigned high priority, but that were absent in patients' top 10.

Abbreviations: N, number of respondents who rated the importance of a topic; SD, standard deviation

![](pone.0128228.t003){#pone.0128228.t003g}

                                                   KIDNEY PATIENTS   CLINICIANS                                                                                                       
  ------------------------------------------------ ----------------- ------------ ------------- ---- ------------- -------------- ---- ------------- ------------- ---- ------------- --------------
  Preservation of veins                            84                18           4.24 (0.51)   3    4.45 (0.36)   **\< 0.01**    2    4.43 (0.33)   **\< 0.01**   2    4.56 (0.34)   **\< 0.001**
  Central vein obstruction                         9                 24           4.22 (0.26)   6    4.40 (0.31)   0.07           7    4.36 (0.29)   0.13          7    4.41 (0.32)   0.06
  Fistula/graft thrombosis                         76                11           4.31 (0.34)   10   4.36 (0.34)   0.18           5    4.40 (0.27)   0.05          11   4.37 (0.35)   0.19
  Fistula/graft stenosis                           76                20           4.24 (0.35)   9    4.37 (0.34)   **\< 0.01**    8    4.36 (0.29)   **\< 0.01**   10   4.38 (0.34)   **\< 0.01**
  Surveillance of fistula/graft (dys)function      76                14           4.26 (0.30)   12   4.34 (0.35)   0.06           10   4.33 (0.34)   0.12          12   4.33 (0.35)   0.14
  Surgical techniques for fistula/graft creation   75                33           4.10 (0.43)   8    4.39 (0.35)   **\< 0.001**   21   4.24 (0.43)   0.02          3    4.54 (0.28)   **\< 0.001**
  Timing of vascular access creation               84                26           4.21 (0.39)   7    4.39 (0.35)   **\< 0.001**   22   4.24 (0.36)   0.50          9    4.38 (0.33)   **0.013**
  Perioperative fistula/graft thrombosis           75                12           4.30 (0.37)   20   4.29 (0.38)   0.71           6    4.37 (0.34)   0.18          21   4.26 (0.35)   0.41

^a)^ Ranking based on mean (standard deviation) standardized ratings

^b)^ Based on two sample t-test of mean standardized ratings between patients and clinician group. P-values of \<0.01 indicate a disagreement on priorities between patients and clinicians, with values between 0.010 and 0.014 being considered borderline significant.

For the remaining four topics in [Table 3](#pone.0128228.t003){ref-type="table"}, we found no evidence for differing priority ratings.

Discussion {#sec021}
==========

Summary of findings {#sec022}
-------------------

In this study, we explored and compared kidney patients\' and clinicians\' perspective on what decisions related to vascular access care deserved priority for coverage by an international guideline. Selection of access type and site, as well as preventing access infections received high priority across respondent groups. Patients generally assigned higher priority to decisions regarding managing adverse effects of arteriovenous access and patient involvement in care, while clinicians more often prioritized decisions around sustaining patients' access options, technical aspects of access creation, and optimizing fistula maturation and patency.

Top priorities for optimizing vascular access decision making {#sec023}
-------------------------------------------------------------

When taking into account both the patient and clinician perspective, the following four vascular access-related decisions emerged as most important: access type selection, access site selection, preventing catheter infection, and preventing fistula/graft infection. These topics should get top priority for the updated ERBP guideline. As part of an international harmonization initiative among seven renal guideline bodies \[[@pone.0128228.ref024]\], ERBP intends to update the systematic reviews underlying the Caring for Australasians with Renal Impairment (CARI) vascular access guidelines \[[@pone.0128228.ref025]--[@pone.0128228.ref027]\]. Apart from informing the clinical side of the decision-making process, the updated evidence synthesis will allow identification of persistent gaps in knowledge. Current research collaboratives focus on improving fistula maturation and patency \[[@pone.0128228.ref028],[@pone.0128228.ref029]\], and our study confirms the relevance of these topics from the clinician perspective. However, based on our findings, health policy makers should additionally consider encouraging initiatives aimed at improving patient outcomes for any access type (not just fistulas), and development of more advanced (statistical) research methods to address the risk of selection bias in non-randomized studies comparing outcomes between access types \[[@pone.0128228.ref008]\].

In keeping with previous studies, our results highlight a strong patient preference regarding access type and site, and the management of access infections \[[@pone.0128228.ref005],[@pone.0128228.ref010],[@pone.0128228.ref011],[@pone.0128228.ref030],[@pone.0128228.ref031]\]. To communicate this, Van der Weijden *et al*. suggested that guidelines should mark these and other patient-priority topics as decisions requiring elicitation of patient preferences \[[@pone.0128228.ref014]\]. This preference elicitation could be accommodated by extending guideline recommendations with information on the patient perspective, or by developing a guideline-based patient decision aid covering these topics \[[@pone.0128228.ref013],[@pone.0128228.ref014],[@pone.0128228.ref032]\]. Readily available qualitative research, such as the recent qualitative evidence synthesis by Casey *et al*. \[[@pone.0128228.ref005]\], may serve as a point of departure.

Differing priorities between patients and clinicians {#sec024}
----------------------------------------------------

Clinicians assigned less priority than patients to decisions around managing adverse effects of arteriovenous access (e.g., fistula/graft-related heart disease) and catheter thrombosis (only surgeons/radiologists). These lower ratings may reflect the relatively low prevalence of such complications in clinicians' daily practice. Nephrologists also gave lower ratings to topics regarding patient involvement in care, potentially indicating unawareness of patient involvement's potential to improve outcomes \[[@pone.0128228.ref033]\]. Others might not recognize the uncertainty around optimal kidney patient involvement in vascular access decisions, or the persistent room for improvement \[[@pone.0128228.ref005],[@pone.0128228.ref009]\]. Future studies investigating nephrologists' knowledge on and attitude towards patient involvement will help to design interventions that foster collaborative vascular access decision making \[[@pone.0128228.ref034]\].

In contrast, preservation of veins received lower priority from patients than from clinicians. This implies that patients do not strongly prefer certain vein preservation strategies to others, and that they would accept the strategy recommended by their doctor. At the same time, our results suggest that clinicians would like a more robust evidence base for recommending how to preserve veins for fistula creation, making this an important topic for guideline development. Patients also gave relatively low priority to topics related to the surgical procedure of arteriovenous access creation. Since we asked patient respondents to assume medical equipoise between treatment options, one explanation for the lack of preference might be that they do not expect choices around access surgery, such as selecting a particular vein for fistula creation or choosing between a synthetic and an autologous graft, to directly affect their lives.

Strengths and limitations {#sec025}
-------------------------

To our knowledge, this is the first study to explore both clinician and kidney patient priorities on all decisions along the vascular access care pathway. Previous studies exploring patients' perspectives on vascular access \[[@pone.0128228.ref005],[@pone.0128228.ref010],[@pone.0128228.ref011],[@pone.0128228.ref030],[@pone.0128228.ref031]\] focused mainly on the choice of access type, and/or did not allow prioritization of patient preference-sensitive decisions; none of them permitted a direct comparison with clinicians' priorities. Our international study sample together with our quantitative approach and analysis strategy, enabled us to draw a detailed and robust picture of priorities among the main stakeholders in vascular access care. This picture complements the results from a recent study in which Canadian clinicians, patients and caregivers identified vascular access as one of the research priorities within the management of kidney failure \[[@pone.0128228.ref035]\]. Furthermore, we suggest that collaborating with kidney patients in developing and executing the survey contributed to successful patient involvement in the early stages of guideline development, which is advocated by broadly accepted guideline development standards \[[@pone.0128228.ref036]--[@pone.0128228.ref038]\].

Our study population likely represented a selected sample of clinicians and kidney patients. This limits the generalizability of our findings, particularly those regarding patient priorities. Patient respondents had to be able and willing to participate, understand the information in the survey, use a computer and email account, and be active in patient organizations. Since patient characteristics, such as higher educational attainment and better self-reported health, potentially increase patients' desire to be involved in treatment selection \[[@pone.0128228.ref039]\], this might have resulted in our overestimating the strength of patients' preferences for some decisions. Selection bias may also explain the low number of patients with a permanent catheter in our sample. This decreased the reliability of patient ratings for the seven catheter-related topics, and thus the probability of finding differences with clinicians\' ratings. Still, the patient ranks were largely comparable to those for similar fistula-related topics. Lastly, kidney patients may be more familiar with common treatments, for example those for managing prevalent complications. Having personal experience with particular treatments potentially affects whether one prefers those treatments to others, with preference strength either increasing or decreasing, depending on the experience itself. Since patients did not report on previous experiences with vascular access care, we were unable to assess how this influenced our findings.

In conclusion, this study provides pointers for optimizing a collaborative decision-making process around vascular access for haemodialysis. In addition to identifying the most pressing knowledge gaps in access care, the findings contribute to developing guidelines that could ultimately improve healthcare professionals' understanding of when and how to involve kidney patients in decisions on the vascular access care pathway.
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